Purpose: Screen for cognitive impairment Age: 18 years and older Admin: Individual Time: 10-15 minutes fir the MMSE-2:SV; 20 minutes for the MMSE-2:EV
With a new standard version that is equivalent to the original MMSE and new and expanded forms, the MMSE-2 retains clinical utility and efficiency while expanding the original's usefulness in populations with milder forms of cognitive impairment, including subcortical dementia.
The original MMSE is one of the most frequently used brief assessments of cognitive impairment. It can be used to track patients' progress over time, to screen large populations for cognitive impairment, and to select patients for clinical trials research in dementia treatment. In revising the the MMSE, the authors sought a variety of improvements, to better standardize its administration, some of the original MMSE items have been altered. Despite these changes, the MMSE-2: Standard Version (MMSE-2:SV) demonstrates high equivalency with the original MMSE. Thus, it is possible to switch from the original MMSE to the MMSE-2:SV without compromising longitudinal data and without any change of the normal range of scores.
An even briefer version, the new MMSE-2: Brief Version (MMSE-2:BV), is designed for rapid assessment in a variety of settings. Available in convenient tear-off pads, the MMSE-2: BV Blue and Red Forms require no stimuli for administration. The MMSE-2: Expanded Version (MMSE-2:EV), a slightly longer version , is more sensitive to subcortical dementia and changes associated with aging; it is sufficiently difficult that it does not a ceiling effect. Equivalent, alternate forms (Blue and Red) of each MMSE-2 verion have been developed to decrease the possibility of practice effects that can occur over serial examinations. Finally, the Pocket Norms Guide has been updated to include norms for versions of the MMSE-2 by age and education level and includes reliable change scores to facilitate serial testing with any of the MMSE-2 versions. Standardization and Development
A new normative sample of more than 1,500 individuals was used to establish reliability and the normal range of scores.A clinical sample consisting of patients with Alzheimer's disease and patients with sucortical dementiawas tested to establish validity. Raw score means and standard deviations by age and education level, as well as age- and education-corrected T scores are provided. Reliability and Validity
Internal consistency ranged from .66 to .79 for the clinical sample. Test-retest stability was calcualted using genralizability (G) coefficients. Convergent validity of the MMSE-2 was examined in termsof its correlations with several tests that purport to measure specific aspects of cognitive function. MMSE-2: Standard Version Kit includes: MMSE-2 User's Manual, 25 MMSE-2:SV Blues Forms, 25 MMSE-2:SV Red Forms, 10 MMSE-2: BV Blue Forms, 10 MMSE-2: BV Red Forms, and Pocket Norms Guide. MMSE-2: Expanded Version includes: MMSE-2 User's Manual, 25 MMSE-2:EV Blues Forms, 25 MMSE-2:EV Red Forms, 2 Processing Speed Scroing Templates [Blue and Red], and Pocket Norms Guide. MMSE-2: Brief Version: A Kit is not available. If Examiner wants to use the Brief Version, the Brief Version Blue Forms, the Brief Version Red Forms, User's Manual and Pocket Norms Guide should be purchased.